VEGF inhibitor PTC299

DRUG2 trials

Sponsors

AIDS Malignancy Consortium, Pediatric Brain Tumor Consortium

Conditions

Brain and Central Nervous System TumorsKaposi's Sarcoma

Phase 1

PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

TerminatedNCT00686842

AIDS Malignancy ConsortiumKaposi's Sarcoma

Start: 2008-09-30End: 2010-12-31Updated: 2018-06-06

PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors

CompletedNCT01158300

Pediatric Brain Tumor ConsortiumBrain and Central Nervous System Tumors

Start: 2010-11-30End: 2015-01-31Updated: 2015-05-04